5-Year Continence Rates, Satisfaction and Adverse Events of Burch Urethropexy and Fascial Sling Surgery for Urinary Incontinence
is corrected by
Abstract
Purpose:
We characterized continence, satisfaction and adverse events in women at least 5 years after Burch urethropexy or fascial sling with longitudinal followup of randomized clinical trial participants.
Materials and Methods:
Of 655 women who participated in a randomized surgical trial comparing the efficacy of the Burch and sling treatments 482 (73.6%) enrolled in this long-term observational study. Urinary continence status was assessed yearly for a minimum of 5 years postoperatively. Continence was defined as no urinary leakage on a 3-day voiding diary, and no self-reported stress incontinence symptoms and no stress incontinence surgical re-treatment.
Results:
Incontinent participants were more likely to enroll in the followup study than continent patients (85.5% vs 52.2%) regardless of surgical group (p <0.0001). Overall the continence rates were lower in the Burch urethropexy group than in the fascial sling group (p = 0.002). The continence rates at 5 years were 24.1% (95% CI 18.5 to 29.7) vs 30.8% (95% CI 24.7 to 36.9), respectively. Satisfaction at 5 years was related to continence status and was higher in women undergoing sling surgery (83% vs 73%, p = 0.04). Satisfaction decreased with time (p = 0.001) and remained higher in the sling group (p = 0.03). The 2 groups had similar adverse event rates (Burch 10% vs sling 9%) and similar numbers of participants with adverse events (Burch 23 vs sling 22).
Conclusions:
Continence rates in both groups decreased substantially during 5 years, yet most women reported satisfaction with their continence status. Satisfaction was higher in continent women and in those who underwent fascial sling surgery, despite the voiding dysfunction associated with this procedure.
References
- 1 : Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database Syst Rev2011; 1. CD001754. Google Scholar
- 2 : Prospective multicentre randomised trial of tension-free vaginal tape and colposuspension as primary treatment for stress incontinence. BMJ2002; 325: 67. Google Scholar
- 3 : A prospective randomized study comparing modified Burch retropubic urethropexy and suburethral sling for treatment of genuine stress incontinence with low-pressure urethra. Am J Obstet Gynecol2000; 182: 30. Google Scholar
- 4 : Complication rates of tension-free midurethral slings in the treatment of female stress urinary incontinence: a systematic review and meta-analysis of randomized controlled trials comparing tension-free midurethral tapes to other surgical procedures and different devices. Eur Urol2008; 53: 288. Google Scholar
- 5 : Design of the Stress Incontinence Surgical Treatment Efficacy Trial (SISTEr). Urology2005; 66: 1213. Google Scholar
- 6 : Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med2007; 356: 2143. Google Scholar
- 7 : Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory: Continence Program in Women (CPW) Research Group. Qual Life Res1994; 3: 291. Google Scholar
- 8 : Classification of surgical complications: a new proposal with evalution in a cohort of 6336 patients and results of a survey. Ann Surg2004; 240: 205. Google Scholar
- 9 : Tension-free vaginal tape versus colposuspension for primary urodynamic stress incontinence: 5-year follow up. BJOG2008; 115: 226. Google Scholar
- 10 : Randomised trial of laparoscopic Burch colposuspension versus tension-free vaginal tape: long-term follow up. BJOG2008; 115: 219. Google Scholar
- 11 : The epidemiology of urinary incontinence in older women: incidence, progression, and remission. J Am Geriatr Soc2008; 56: 1191. Google Scholar
- 12 : Mixed incontinence: comparing definitions in women having stress incontinence surgery. Neurourol Urodyn2009; 28: 268. Google Scholar
- 13 : Quality of life after surgery for stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct2008; 19: 1631. Google Scholar
